• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺瘤病恶性转化为具有侵袭性生长和远处转移的甲状旁腺癌。

Malignant transformation of parathyromatosis to parathyroid carcinoma with invasive growth and distant metastasis.

作者信息

Harinarayan Chittari Venkata, Ranjoalkar Anugnya Premdas, Tandon Anisha Sawkar, Ashok Honey, Prashant Madhu

机构信息

Institute of Endocrinology, Diabetes, Thyroid and Osteoporosis Disorders, Sakra World Hospitals, Bangalore, Karnataka State, India.

Department of Medicine & Endocrinology, Saveetha Institute of Medical and Technical Sciences University, Saveetha Medical College, Chennai, India.

出版信息

Endocr Oncol. 2025 May 31;5(1):e250024. doi: 10.1530/EO-25-0024. eCollection 2025 Jan.

DOI:10.1530/EO-25-0024
PMID:40462864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12131739/
Abstract

UNLABELLED

Parathyroid carcinoma (PC) is a rare endocrine malignancy. It accounts for about 1% of all primary hyperparathyroidism (PHPT) cases and 0.005% of all malignancies. PC presents with severe hypercalcemia, often refractory to standard medical treatment, which is crucial for improving patient outcomes. Differentiating PC from atypical parathyroid adenomas and parathyromatosis can be challenging. PC is diagnosed by angio-invasion, lymphatic and perineural invasion, and local malignant invasion with regional and distant metastasis. CD31 positivity on immunohistochemistry, indicating tumor cells within blood vessels in the pseudocapsule (vascular invasion), and a Ki-67% proliferative index of 8% confirm the diagnosis. We describe a 67-year-old man who presented with neck swelling, abdominal pain, and weight loss. Five years prior, he underwent a left inferior parathyroidectomy for a mass, which histological examination identified as clear cell parathyroid adenoma. Three years post-parathyroidectomy, he developed recurrent left-sided neck swelling. Magnetic resonance imaging revealed a lesion with mediastinal extension but no lymph node metastasis. During surgery, the lesion was adherent to the common carotid artery, and histopathological examination confirmed parathyromatosis. Recently, he presented again with new-onset neck swelling, abdominal pain, and weight loss. Biochemical investigations confirmed primary hyperparathyroidism. Invasive growth into surrounding tissues, blood vessels, and nerves, along with lymph node involvement and lung metastasis, with histopathology showing CD31 positivity and a Ki-67% proliferative index of 8%, confirmed the diagnosis of PC. As the tumor was inoperable, hypercalcemia was managed with cinacalcet, resulting in a decline in serum calcium levels.

LEARNING POINTS

Parathyroid carcinoma is one of the rarest malignancies.Parathyromatosis is parathyroid tissue displaced in the neck and mediastinum due to prior surgery or aberrant embryonic development.The diagnosis of parathyroid carcinoma on histopathology is based on:Local invasion into adjacent structures, such as adipose tissues/skeletal muscle bundles.Loco-regional invasion-lymphatic (D240 IHC+), angio-invasion (CD31 IHC+), and perineural invasion.Nuclear pleomorphism, hyperchromatic nuclei, and increased mitosis (high Ki-67 proliferative index of >5%).Regional and distant metastasis in the lungs and other organs.Management of severe hypercalcemia is crucial for improving patient outcomes.

摘要

未标记

甲状旁腺癌(PC)是一种罕见的内分泌恶性肿瘤。它约占所有原发性甲状旁腺功能亢进症(PHPT)病例的1%,占所有恶性肿瘤的0.005%。PC表现为严重高钙血症,通常对标准药物治疗无效,这对改善患者预后至关重要。将PC与非典型甲状旁腺腺瘤和甲状旁腺增生症区分开来可能具有挑战性。PC通过血管侵犯、淋巴管和神经侵犯以及局部恶性侵犯伴区域和远处转移来诊断。免疫组织化学检测中CD31阳性,表明假包膜内血管中有肿瘤细胞(血管侵犯),Ki-67%增殖指数为8%可确诊。我们描述了一名67岁男性,他出现颈部肿胀、腹痛和体重减轻。五年前,他因肿块接受了左下甲状旁腺切除术,组织学检查确定为透明细胞甲状旁腺腺瘤。甲状旁腺切除术后三年,他出现左侧颈部反复肿胀。磁共振成像显示一个病变延伸至纵隔但无淋巴结转移。手术中,病变与颈总动脉粘连,组织病理学检查确诊为甲状旁腺增生症。最近,他再次出现新发颈部肿胀、腹痛和体重减轻。生化检查证实为原发性甲状旁腺功能亢进症。肿瘤侵入周围组织、血管和神经,伴有淋巴结受累和肺转移,组织病理学显示CD31阳性且Ki-67%增殖指数为8%,确诊为PC。由于肿瘤无法手术切除,高钙血症采用西那卡塞治疗,血清钙水平下降。

学习要点

甲状旁腺癌是最罕见的恶性肿瘤之一。甲状旁腺增生症是由于先前手术或胚胎发育异常导致甲状旁腺组织移位至颈部和纵隔。甲状旁腺癌的组织病理学诊断依据为:局部侵犯相邻结构,如脂肪组织/骨骼肌束。局部区域侵犯——淋巴管侵犯(免疫组织化学D240阳性)、血管侵犯(CD31免疫组织化学阳性)和神经侵犯。核多形性、核深染和有丝分裂增加(Ki-67增殖指数>5%)。肺和其他器官的区域和远处转移。严重高钙血症的管理对改善患者预后至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795b/12131739/d50f08783018/EO-25-0024fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795b/12131739/d50f08783018/EO-25-0024fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/795b/12131739/d50f08783018/EO-25-0024fig1.jpg

相似文献

1
Malignant transformation of parathyromatosis to parathyroid carcinoma with invasive growth and distant metastasis.甲状旁腺瘤病恶性转化为具有侵袭性生长和远处转移的甲状旁腺癌。
Endocr Oncol. 2025 May 31;5(1):e250024. doi: 10.1530/EO-25-0024. eCollection 2025 Jan.
2
Distinguishing Parathyromatosis, Atypical Parathyroid Adenomas, and Parathyroid Carcinomas Utilizing Histologic and Clinical Features.利用组织学和临床特征鉴别甲状旁腺瘤病、非典型甲状旁腺腺瘤和甲状旁腺癌。
Head Neck Pathol. 2021 Sep;15(3):727-736. doi: 10.1007/s12105-020-01281-6. Epub 2021 Jan 4.
3
Parathyroid Carcinoma Complicated by Parathyromatosis and Refractory Hypercalcemia.甲状旁腺癌合并甲状旁腺瘤病及难治性高钙血症
Cureus. 2024 Oct 28;16(10):e72584. doi: 10.7759/cureus.72584. eCollection 2024 Oct.
4
Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis?甲状旁腺癌、非典型甲状旁腺腺瘤还是甲状旁腺增生症?
Cancer. 2007 Jul 15;110(2):255-64. doi: 10.1002/cncr.22790.
5
Effective long-term management of parathyromatosis-related refractory hypercalcemia with a combination of denosumab and cinacalcet treatment.地诺单抗和西那卡塞联合治疗甲状旁腺瘤病相关难治性高钙血症的有效长期管理。
Hormones (Athens). 2022 Mar;21(1):171-176. doi: 10.1007/s42000-021-00343-w. Epub 2022 Jan 7.
6
[Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience].[甲状旁腺癌。基于20年经验的治疗策略]
Minerva Endocrinol. 2001 Mar;26(1):23-9.
7
Recurrent renal secondary hyperparathyroidism caused by supernumerary mediastinal parathyroid gland and parathyromatosis: A case report.由纵隔甲状旁腺增生和甲状旁腺瘤病引起的复发性肾继发性甲状旁腺功能亢进:一例报告。
Front Surg. 2023 Mar 20;10:1135596. doi: 10.3389/fsurg.2023.1135596. eCollection 2023.
8
Case series of diagnosis and surgery challenges in parathyroid carcinoma.甲状旁腺癌诊断与手术挑战的病例系列
Int J Surg Case Rep. 2022 Aug;97:107390. doi: 10.1016/j.ijscr.2022.107390. Epub 2022 Jul 9.
9
Recurrence hyperparathyroidism caused by synchronous parathyroid carcinoma and parathyromatosis in a patient with long-term hemodialysis.长期血液透析患者中由甲状旁腺癌和甲状旁腺瘤病引起的复发性甲状旁腺功能亢进症。
BMC Nephrol. 2023 Oct 4;24(1):293. doi: 10.1186/s12882-023-03328-6.
10
Defining a molecular phenotype for benign and malignant parathyroid tumors.定义良性和恶性甲状旁腺肿瘤的分子表型。
Cancer. 2009 Jan 15;115(2):334-44. doi: 10.1002/cncr.24037.

本文引用的文献

1
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases.转移性甲状旁腺癌的治疗与转归:已发表病例的系统评价与汇总分析
Front Oncol. 2022 Sep 26;12:997009. doi: 10.3389/fonc.2022.997009. eCollection 2022.
2
Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.甲状旁腺肿瘤的免疫组织化学特征:全面综述。
Int J Mol Sci. 2022 Jun 23;23(13):6981. doi: 10.3390/ijms23136981.
3
Overview of the 2022 WHO Classification of Parathyroid Tumors.《2022 年世卫组织甲状旁腺肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17.
4
Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.地舒单抗治疗甲状旁腺癌高钙血症 1 例报告
Front Endocrinol (Lausanne). 2022 Jan 31;12:794988. doi: 10.3389/fendo.2021.794988. eCollection 2021.
5
Distinguishing Parathyromatosis, Atypical Parathyroid Adenomas, and Parathyroid Carcinomas Utilizing Histologic and Clinical Features.利用组织学和临床特征鉴别甲状旁腺瘤病、非典型甲状旁腺腺瘤和甲状旁腺癌。
Head Neck Pathol. 2021 Sep;15(3):727-736. doi: 10.1007/s12105-020-01281-6. Epub 2021 Jan 4.
6
Immunohistochemistry in Diagnostic Parathyroid Pathology.免疫组织化学在诊断甲状旁腺病理学中的应用。
Endocr Pathol. 2018 Jun;29(2):113-129. doi: 10.1007/s12022-018-9527-6.
7
Parathyroid carcinoma: challenges in diagnosis and treatment.甲状旁腺癌:诊断与治疗面临的挑战。
Hematol Oncol Clin North Am. 2012 Dec;26(6):1221-38. doi: 10.1016/j.hoc.2012.08.009. Epub 2012 Oct 5.
8
Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism.甲状旁腺腺瘤病:一种罕见但成问题的复发性和持续性甲状旁腺功能亢进的病因。
Metabolism. 2012 Jun;61(6):762-75. doi: 10.1016/j.metabol.2011.11.001. Epub 2012 Jan 4.
9
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.盐酸西那卡塞可降低无法手术的甲状旁腺癌患者的血清钙浓度。
J Clin Endocrinol Metab. 2007 Oct;92(10):3803-8. doi: 10.1210/jc.2007-0585. Epub 2007 Jul 31.
10
Parathyromatosis: a cause for recurrent hyperparathyroidism.甲状旁腺瘤病:复发性甲状旁腺功能亢进的一个病因。
Endocr Pract. 2001 May-Jun;7(3):189-92. doi: 10.4158/EP.7.3.189.